LAUSR

References 1 As kın € O, Engin B, Gencebay G, T€ uz€ un Y. A multistep approach to the diagnosis of rare genodermatoses. Clin Dermatol. 2020;38:399–407. 2 Chiu FP-C, Doolan BJ, McGrath JA, Onoufriadis A. A decade of next-generation sequencing in genodermatoses: the impact on gene discovery and clinical diagnostics. Br J Dermatol. 2021;184:606–16. 3 Paananen J, Fortino V. An omics perspective on drug target discovery platforms. Brief Bioinform. 2020;21:1937–53. 4 Onoufriadis A, Proudfoot LE, Ainali C, Torre D, Papanikolaou M, Rayinda T, et al. Transcriptomic profiling of recessive dystrophic epidermolysis bullosa wounded skin highlights drug repurposing opportunities to improve wound healing. Exp Dermatol. 2022;31:420–6. 5 Morren M-A, Legius E, Giuliano F, Hadj-Rabia S, Hohl D, Bodemer C. Challenges in treating genodermatoses: new therapies at the horizon. Front Pharmacol. 2021;12:746664.